Results 231 to 240 of about 8,446 (302)
What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi +29 more
wiley +1 more source
Community readiness for the program of all-inclusive care for the elderly (PACE): A qualitative study with Korean Americans in Los Angeles. [PDF]
Park J +5 more
europepmc +1 more source
Quantifying Protein–Glycan Interactions Using Native Mass Spectrometry
ABSTRACT Interactions between glycan‐binding proteins (GBPs) and carbohydrates (glycans) are essential to many biological processes relevant to human health and disease. For most GBPs, however, their glycan interactome—the repertoire of glycans recognized and their specificities—is poorly defined.
Duong T. Bui +4 more
wiley +1 more source
Protein quality and allergenicity assessment of chia seeds (<i>Salvia hispanica</i>): a molecular perspective on novel food safety. [PDF]
Calcinai L +5 more
europepmc +1 more source
Social CRM, la nueva forma de relación entre empresas y clientes
Cibersur
openalex +1 more source
Early Phase Dose‐Finding Designs for CAR‐T Cell Therapies
ABSTRACT Chimeric Antigen Receptor (CAR)‐T cell is an immunotherapy which revolutionised the treatment of relapsed/refractory lymphoma and leukaemia. It is shown to have a higher response rate, higher mid‐to‐long term overall survival, and lower toxicity than standard treatments.
Weishi Chen +3 more
wiley +1 more source
Translational framework for implementation evaluation and research: a critical approach to patient-centred equity design. [PDF]
May CR +16 more
europepmc +1 more source
Laboratoire de recherche historique Rhône-Alpes, CNRS / Université de Lyon +1 more
openalex +1 more source
Customer Satisfaction and Profit Enhancement through Social CRM
P. Menaka +3 more
openalex +1 more source

